Hong Kong Market Close: Hang Seng Index Up 0.6%, Commercial Aerospace Surges, Computing Power Stocks Pull Back
nashnova research
The Hang Seng Index closed up 0.6% at 24,175 on July 10 as afternoon flows rotated sharply out of chip-hardware names and into commercial space and innovative pharma — a rocket-recovery breakthrough and a drug-catalog overhaul each lit a fresh thematic line while lockup-expiry pressure dragged AI-compute stocks lower.
How did the broader market finish?
The HSI closed at 24,175.12, up 0.6%. The Hang Seng Tech Index flipped negative in the afternoon, ending down 0.21% at 4,721.66. Turnover hit HK$339.6 billion.
For the week, the HSI gained 3.53%, the HSCEI 4.41%, and the Tech Index 4.95%.
This means → all three benchmarks posted solid weekly gains, but Friday's late tech sell-off signals money actively trimmed tech exposure ahead of the weekend.
A rocket landed — why did space stocks take off?
China's Long March 10B lifted off on July 10 and its first-stage booster landed vertically on a sea platform — making China the second country to master large-payload reusable-rocket technology.
The news ignited the sector in the afternoon: Junda Holdings surged 24.2%, Goldwind Technology rose 8.4%, APT Satellite gained 4.27%.
In plain terms = a reusable rocket slashes launch costs; cheaper launches make mass satellite-constellation deployment viable. Everbright Securities sees the industry unfolding along one chain: cut costs → deploy satellites → build networks → unlock downstream apps.
What is driving the innovative-pharma rally?
Three government agencies on July 9 published the 2026 National Essential Medicines List, adding 16 innovative drugs for the first time in bulk — including 4 domestically developed Class-I new drugs.
In plain terms = landing on the essential list means hospitals must prioritize procurement, giving sales a policy floor.
Kelun-Biotech rose 8.74%, SSY Group gained 6.29%, InnoCare climbed 4.25%. Extra fuel: China's first-half 2026 out-licensing deals totaled US$99.7 billion, already 73% of 2025's full-year figure.
Why did chip-hardware stocks sell off instead?
GigaDevice (03986) tumbled 21.05% to HK$742.5. The trigger: 18 cornerstone investors will see a combined 14.39 million H-shares exit lockup on July 13.
This means → even though the company disclosed first-half net profit growth of roughly 1,099% (about RMB 6.9 billion), the looming supply of unlocked shares overwhelmed the earnings beat.
SMIC fell 4.67%, dragging the HSI down by 25.01 points on its own. Semis, PCBs, and optical-comms names all opened high and faded, becoming the day's biggest drag.
Which blue chips and momentum names stood out?
CK Hutchison led blue chips, up 7.53% at HK$70, contributing 20.07 points to the HSI. The catalyst: the company is in talks to sell its European perfume-and-cosmetics unit Marionnaud.
Leapmotor jumped 6.79% — first-half EV registrations in Italy soared 1,448.8% year-on-year, lifting its Italian BEV market share to 29.4%. Pegbio surged 28.93% after announcing an oral-delivery collaboration with Nasdaq-listed Rani Therapeutics targeting obesity.
Most mega-cap tech names closed higher: Xiaomi up over 3%, JD.com, Kuaishou, and Alibaba each up over 2%. CATL fell 7.92%, dragging the HSI down 15.99 points.
After the rotation, what comes next?
The afternoon flow was clear: money left chip hardware for commercial space and innovative pharma. Two IPOs debuted with divergent results — Nexchip held flat while Binhua dropped 18.68%, touching −24% intraday.
This means → the market is not rising uniformly; capital is choosing between sectors. Whether commercial space becomes a lasting theme depends on industrialization pace; whether pharma can hold its valuation hinges on mid-year earnings delivery.
In plain terms = today's rotation shows money is hunting for the next narrative, but how long the story lasts still comes down to whether fundamentals can keep up.
市场有风险，内容仅供研究参考，不构成投资建议。